Clinical Personalized Medicine for Parkinson's Disease and Implications on Sleep Dysfunction

Personalized medicine (PM) for Parkinson's disease (PD) can range from precision genomic therapies such as ambroxol in glucocerebrosidase mutation-linked PD to treatment tailored for sleep dysfunction in nonmotor subtypes of PD. Additionally, in future pharmacogenetics may also play a part by i...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Sleep medicine clinics Ročník 20; číslo 3; s. 417
Hlavní autori:	Metta, Vinod, Popławska-Domaszewicz, Karolina, Chen, Rosabel, Chaudhuri, K Ray
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.09.2025
Predmet:	Humans Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson Disease - genetics Parkinson Disease - therapy Precision Medicine - methods Sleep Wake Disorders - drug therapy Sleep Wake Disorders - etiology Sleep Wake Disorders - therapy Pharmacogenetics Sleep dysfunction Precision medicine Genomic medicine Insomnia pharmacogenetics Personalised medicine Subtype Parkinson’s disease
ISSN:	1556-4088
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!